Two years ago, the 3-year results of the Ahmed Baerveldt Comparison (ABC) were released. For further follow-up, the study group is presenting the 5-year outcomes. A total of 276 patients initially ...

Please provide your email address to receive an email when new articles are posted on . Despite monumental achievements in the field of MIGS, glaucoma filtering surgery is still often required for ...

The use of aqueous shunts for the management of refractory glaucoma is increasing compared with trabeculectomy. The number of shunts being placed increased 184% from 1995 to 2004. Commonly used ...

Glaucoma, an eye disease that can cause irreversible blindness, is a major health concern worldwide. It is caused by a build-up of fluid in the eye, which leads to increased pressure inside the eye.

While the Xen 45 gel stent implant showed beneficial long-term outcomes for the treatment of open-angle glaucoma, a substantial proportion of patients needed follow-up operations or bleb needling, ...

Glaucoma, which affects an estimated 57 million people worldwide, is an eye condition caused by too much pressure around the eye, which can damage the optical nerve and lead to irreversible blindness.

Surgery is considered when medications aren’t enough to treat glaucoma. Surgical options include trabeculectomy, tube shunt implantation, MIGS, and cyclophotocoagulation, each of which aims to lower ...

Glaucoma surgeon George Baerveldt, MD, has joined NVISION Laser Eye Centers in California, according to a news release. NVISION has 15 locations throughout Southern California. Dr. Baerveldt will be ...